retrosternal mass: an interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke.

نویسندگان

masoud mehrpour assistant professor, department of neurology and firoozgar hospital, tehran university of medical sciences, tehran, iran.

mohammad reza motamed health policy research center, shiraz university of medical sciences, shiraz, iran

mahboubeh aghaei health policy research center, shiraz university of medical sciences, shiraz, iran

zahra badi research center for traditional medicine and history of medicine and department of neurology, shiraz university of medical sciences, shiraz, iran

چکیده

stroke is an important cause of disability and death worldwide, with the majority of strokes occurring in older people. thrombolysis with recombinant tissue plasminogen activator (r-tpa) is the approved treatment for acute ischemic stroke. a major concern of physicians, who treat acute ischemic stroke with recombinant tissue plasminogen activator (r-tpa,) is the risk of intracerebral hemorrhage. however, other adverse reactions, including anaphylaxis and angioedema, can also occur. here we report an interesting soft tissue reaction to intravenous r-tpa in an 80 year-old male who was treated for acute ischemic stroke.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke

Stroke is an important cause of disability and death worldwide, with the majority of strokes occurring in older people. Thrombolysis with recombinant tissue plasminogen activator (r-TPA) is the approved treatment for acute ischemic stroke. A major concern of physicians, who treat acute ischemic stroke with recombinant tissue plasminogen activator (r-TPA,) is the risk of intracerebral hemorrhage...

متن کامل

Intravenous thrombolytic therapy for acute ischemic stroke.

n engl j med 364;22 nejm.org june 2, 2011 2138 This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented...

متن کامل

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

n engl j med 364;22 nejm.org june 2, 2011 2138 This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented...

متن کامل

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke

  Background: Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagic transformation is the greatest complication of this treatment, which may occur after recanalization of occluded artery. The aim of this study was to determine factors associated with clinical improvement and worsening in patients with acute ischemic stroke treated with intravenous th...

متن کامل

eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation

conclusions: the major barriers for thrombolytic therapy for patients with ais in this setting were delays in the provision of in-hospital services, like initial patient assessment, ct scans or laboratory studies. these results were in contrast with previous reports. background: intravenous thrombolysis is an approved treatment method for patients with acute ischemic stroke (ais) and is recomme...

متن کامل

Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation

BACKGROUND Intravenous thrombolysis is an approved treatment method for patients with acute ischemic stroke (AIS) and is recommended by multiple guidelines. However, it seems that it is less frequently used in the developing countries compared to the developed countries. OBJECTIVES The purpose of this study was to estimate the percentage of patients with AIS, eligible for intravenous thrombol...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of neurology

جلد ۱۲، شماره ۳، صفحات ۱۱۴-۱۱۶

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023